Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia

Table 1

Baseline characteristics of participants by myalgia status^a,b,c.

	Nonmyalgic sample ()	Myalgic sample ()
Age, y	60.9 ± 8.5	59.1 ± 10.0
Men, (%)	42 (55%)	25 (66%)
Height, m	1.7 ± 0.1	1.7 ± 0.1
Weight, kg	80.8 ± 15.8	87.4 ± 17.9
BMI, kg/m^2	27.7 ± 4.2	29.8 ± 5.2
SBP, mmHg	123.4 ± 13.7	121.5 ± 13.1
DBP, mmHg	74.9 ± 6.4	75.1 ± 6.9
Time on simvastatin, wks	7.3 ± 1.6	3.8 ± 2.0
TC, mmol/L	6.56 ± 1.14	6.35 ± 1.04
LDL-C, mmol/L	4.23 ± 1.00	4.11 ± 0.80
HDL-C, mmol/L	1.41 ± 0.38	1.33 ± 0.39
TG, mmol/L	4.51 ± 2.85	4.57 ± 2.98

^aData are means ± SD or proportions. ^bBMI, body mass index; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides. ^cPlasma lipid levels assessed prior to initiating simvastatin or placebo treatment did not differ () and therefore were averaged. between samples.